The New York Times. It also comes shortly after two notable developments regarding COVID-19 treatment. On June 16, the National Institutes of Health released research on a cancer drug that may reduce severe COVID-19 symptoms.
In the United Kingdom, researchers found evidence that the steroid dexamethasone had reduced COVID-19 deaths of severely ill patients by up to one third.RELATED: First drug proves able to improve survival from coronavirusOn June 15, the Food and Drug Administration (FDA) rescinded its emergency use authorization of hydroxychloroquine and chloroquine, drugs that had been previously touted by President Donald Trump as unproven treatments for COVID-19, and one that the president said he was taking himself to ward off.